Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qinggong Changchun Capsules (清宫长春胶囊) is a Traditional Chinese Medicine (TCM) herbal product manufactured by Chengde Jingfukang Pharmaceutical. It is classified as a tonic (补益类) and is based on traditional imperial court formulas intended to tonify the kidney and spleen while nourishing qi and blood. The medication is primarily indicated for patients suffering from deficiencies in qi and blood, which manifest as physical weakness, fatigue, dizziness, palpitations, and insomnia. As a complex herbal formulation, it utilizes a synergistic blend of botanical ingredients to restore internal balance and vitality. It is an approved pharmaceutical product in China, administered orally in capsule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qinggong Changchun Capsules.